Webrix

Webrix (afatinib) is an oral medication prescribed for certain types of cancer. It belongs to the tyrosine kinase inhibitor class and is used to treat specific lung cancers. This page provides neutral, factual details about afatinib for informational purposes only.

Afatinib is primarily used to treat non-small cell lung cancer (NSCLC) in patients with specific genetic mutations. It works by blocking signals that promote cancer cell growth. This medication is often prescribed for advanced or metastatic cases where targeted therapy is appropriate. It is also used in some cases of squamous cell lung cancer after chemotherapy.

Common effects of afatinib may include diarrhea, skin rash, and fatigue. Some users report mouth sores or reduced appetite. These effects vary by individual and should be discussed with a healthcare provider.

Afatinib should be handled with care, especially by those with known allergies to its components. Pregnant or breastfeeding individuals should avoid use unless directed by a doctor. Regular medical monitoring is recommended during treatment to assess response and manage side effects.

Afatinib may interact with other medications, including certain antibiotics, antifungals, and herbal supplements. Grapefruit products can affect how the drug is processed in the body. Always inform your healthcare provider about all medications and supplements you are taking before starting afatinib.